Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells

Abstract

Survival of patients with Glioblastoma Multiforme (GM), a highly malignant brain tumor, remains poor despite concerted efforts to improve therapy. The median survival of patients with GM has remained approximately 1 year regardless of the therapeutic approach. Since radiation therapy is the most effective adjuvant therapy for GM and nearly half of GM tumors harbor p53 mutations, we sought to identify genes that mediate p53-independent apoptosis of GM cells in response to ionizing radiation. Using broad-scale gene expression analysis we found that following radiation treatment, TRADD expression was induced in a uniquely radiosensitive GM cell line but not in radioresistant GM cell lines. TRADD over-expression killed GM cells and activated NF-κB. We found that blocking the TRADD-mediated pathway using a dominant-negative mutant of FADD (FADD-DN) enhanced radiation resistance of GM cells, as reflected in both susceptibility to apoptosis and clonogenic survival following irradiation. Conversely, stable expression of exogenous TRADD enhanced radiation-induced apoptosis of GM cell lines, reflecting the biological significance of TRADD regulation in p53-independent apoptosis. These findings generate interest in utilizing TRADD in gene therapy for GM tumors, particularly in light of its dual function of directly inducing rapid apoptosis and sensitizing GM cells to standard anti-neoplastic therapy.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP . 1995 J. Biol. Chem. 270: 19181–19187

  • Albright N . 1987 Radiat. Res. 112: 331–340

  • Baker SJ, Reddy EP . 1998 Oncogene 17: 3261–3270

  • Barr PJ, Tomei LD . 1994 Biotechnology (NY) 12: 487–493

  • Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin KM . 1996 Blood 88: 1741–1746

  • Brown JM, Wouters BG . 1999 Cancer Res. 59: 1391–1399

  • Chen P, Iavarone A, Fick J, Edwards M, Prados M, Israel MA . 1995 Cancer Genet. Cytogenet. 82: 106–115

  • Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM . 1996 J. Biol. Chem. 271: 4961–4965

  • Datta R, Hass R, Gunji H, Weichselbaum R, Kufe D . 1992 Cell Growth Differ. 3: 637–644

  • DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ . 1999 Clin. Cancer Res. 5: 3219s–3223s

  • el-Deiry WS . 1998 Semin. Cancer Biol. 8: 345–357

  • Ferrer I . 1992 Brain Res. 588: 351–357

  • Ferrer I, Macaya A, Blanco R, Olivé M, Cinós C, Munell F, Planas AM . 1995 Int. J. Dev. Neurosci. 13: 21–28

  • Fertil B, Malaise EP . 1985 Int. J. Radiat. Oncol. Biol. Phys. 11: 1699–1707

  • French LE, Tschopp J . 1999 Nat. Med. 5: 146–147

  • Frenkel J, Sherman D, Fein A, Schwartz D, Almog N, Kapon A, Goldfinger N, Rotter V . 1999 Oncogene 18: 2901–2907

  • Friesen C, Herr I, Krammer PH, Debatin KM . 1996 Nat. Med. 2: 574–577

  • Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM . 1997 Cancer Res. 57: 3823–3829

  • Gallagher WM, Brown R . 1999 Ann. Oncol. 10: 139–150

  • Goswami PC, Roti Roti JL, Hunt CR . 1996 Mol. Cell. Biol. 16: 1500–1508

  • Guo N, Faller DV, Vaziri C . 2000 J. Biol. Chem. 275: 1715–1722

  • Gura T . 1997 Science 277: 768

  • Haas-Kogan DA, Dazin P, Hu L, Deen DF, Israel MA . 1996a Cancer J. Sci. Am. 2: 114–121

  • Haas-Kogan DA, Yount G, Haas M, Levi D, Kogan SS, Hu L, Vidair C, Deen DF, Dewey WC, Israel MA . 1996b Int. J. Radiat. Oncol. Biol. Phys. 36: 95–103

  • Hagiyama H, Adachi T, Yoshida T, Nomura T, Miyasaka N, Honjo T, Tsubata T . 1999 Oncogene 18: 4091–4098

  • Herr I, Wilhelm D, Böhler T, Angel P, Debatin KM . 1997 EMBO J. 16: 6200–6208

  • Hsu H, Shu HB, Pan MG, Goeddel DV . 1996 Cell 84: 299–308

  • Hsu H, Xiong J, Goeddel DV . 1995 Cell 81: 495–504

  • Itoh N, Nagata S . 1993 J. Biol. Chem. 268: 10932–10937

  • Joneson T, Bar-Sagi D . 1999 Mol. Cell. Biol. 19: 5892–5901

  • Kane LP, Shapiro VS, Stokoe D, Weiss A . 1999 Curr. Biol. 9: 601–604

  • Klefstrom J, Arighi E, Littlewood T, Jäättelä M, Saksela E, Evan GI, Alitalo K . 1997 EMBO J. 16: 7382–7392

  • Knudsen KE, Fribourg AF, Strobeck MW, Blanchard JM, Knudsen ES . 1999 J. Biol. Chem. 274: 27632–27641

  • Kolbus A, Herr I, Schreiber M, Debatin KM, Wagner EF, Angel P . 2000 Mol. Cell. Biol. 20: 575–582

  • Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA . 1994 Genes Dev. 8: 1613–1626

  • Ludgate CM, Douglas BG, Dixon PF, Steinbok P, Jackson SM, Goodman GB . 1988 Int. J. Radiat. Oncol. Biol. Phys. 15: 1091–1095

  • Merritt AJ, Allen TD, Potten CS, Hickman JA . 1997 Oncogene 14: 2759–2766

  • Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR . 1997 J. Clin. Invest. 99: 403–413

  • Murphy S . 1990 Generation of astrocyte cultures from normal and neoplastic central nervous system In Michael P. (ed.). Methods in Neurosciences: Cell Culture Academic Press pp. 33–47

  • Muschel RJ, Zhang HB, Iliakis G, McKenna WG . 1991 Cancer Res. 51: 5113–5117

  • Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E, Radinsky R . 1995 Mol. Cell. Biol. 15: 3032–3040

  • Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM . 1997a Science 277: 815–818

  • Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM . 1997b Science 276: 111–113

  • Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A . 1996 J. Biol. Chem. 271: 12687–12690

  • Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB . 1998 Int. J. Radiat. Oncol. Biol. Phys. 40: 57–63

  • Sarkar A, Dolan ME, Gonzalez GG, Marton LJ, Pegg AE, Deen DF . 1993 Cancer Chemother. Pharmacol. 32: 477–481

  • Sheline GE . 1977 Cancer 39: 873–881

  • Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A . 1997 Science 277: 818–821

  • Taghian A, Suit H, Pardo F, Gioioso D, Tomkinson K, DuBois W, Gerweck L . 1992 Int. J. Radiat. Oncol. Biol. Phys. 23: 55–62

  • Tartaglia LA, Ayres TM, Wong GH, Goeddel DV . 1993 Cell 74: 845–853

  • Trudel M, Lanoix J, Barisoni L, Blouin MJ, Desforges M, L'Italien C, D'Agati V . 1997 J. Exp. Med. 186: 1873–1884

  • Uberti D, Schwartz D, Almog N, Goldfinger N, Harmelin A, Memo M, Rotter V . 1999 Exp. Cell Res. 252: 123–133

  • Villa R, Zaffaroni N, Bearzatto A, Costa A, Sichirollo A, Silvestrini R . 1996 Int. J. Cancer 66: 104–109

  • Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH . 1999 Nat. Med. 5: 157–163

  • Weinstein J . 1997 J. Biol. Chem. 272: 28501–28511

  • Weinstein J, Karim J, Geschwind DH, Nelson SF, Krumm J, Sakamoto KM . 1998 Mol. Genet. Metab. 64: 52–57

  • Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin G . 1995 Immunity 3: 673–682

  • Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, el-Deiry WS . 1997 Nat. Genet. 17: 141–143

  • Yuan ZM, Utsugisawa T, Ishiko T, Nakada S, Huang Y, Kharbanda S, Weichselbaum R, Kufe D . 1998 Oncogene 16: 1643–1648

Download references

Acknowledgements

We gratefully acknowledge Drs David Stokoe, Osamu Tetsu, Peter Sabbatini and Alexander Gottschalk for their valuable comments and discussion. We thank DV Geoddel for the pRK-TRADD plasmid, VM Dixit for the pcDNA3-FADD-DN plasmid, and P Rodriguez-Viciana for the pBabeHygro retroviral vector. This work was supported by NIH grant M01 RR01271, Pediatric Clinical Research Center, (D Haas-Kogan) and a Pfizer Scholar Grants for New Faculty (D Haas-Kogan).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yount, G., Afshar, G., Ries, S. et al. Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells. Oncogene 20, 2826–2835 (2001). https://doi.org/10.1038/sj.onc.1204393

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204393

Keywords

This article is cited by

Search

Quick links